For CLIA, CAP and ISO 15189 laboratories

Method validation,
from plan to signature.

Plan the study. Import the results. Run the statistics. Sign the report.

ChemistryGlucose, new analyzer

Sample project, synthetic data
  1. Plan
  2. Data
  3. Analysis
  4. Review
  5. Sign
Method comparisonCHM-02 vs CHM-01, mg/dL

Acceptance rule

Slope 0.95 to 1.05

Locked before data, plan v1

Pairs
60
Slope
0.970
95% CI
0.954 to 0.987
Intercept
1.28

Criterion met

Pair 54 residual 12.1 mg/dL

Investigate

Computed live in your browser from 60 synthetic glucose pairs by Passing-Bablok regression.

How a study moves.

  1. 01

    Plan

    Slope 0.95 to 1.05Bias within 6 mg/dLApproved, locked
  2. 02

    Import

    #CHM-01CHM-02
    181.278.4
    2124.4124.5
    362.263.4
    60 rows, 0 errors
  3. 03

    Analyze

  4. 04

    Investigate

    171.2 mg/dL original keptRerun on a second analyzer.
  5. 05

    Sign

    Technical reviewerLaboratory director

The performance specs, mapped to studies.

Unmodified FDA-cleared test, 42 CFR 493.1253(b)(1)

  • AccuracyMethod comparisonEP09
  • PrecisionRepeatability and within-labEP15
  • Reportable rangeLinearity and recoveryEP06
  • Reference intervalsTransference, 2 of 20EP28
  • Analytical sensitivityDetection limitEP17
  • Analytical specificityInterferenceEP07

The statistics, labeled honestly.

    See all 36 packages

    Validation Studio is in preview. Each laboratory accepts a method before operational use.

    Already using Validation Studio?

    Sign in